FDA-Inspected Site

Liebel-Flarsheim Company LLC

6 FDA inspections are on record for Liebel-Flarsheim Company LLC in Cincinnati, United States.

483· Form 483 issued

Cincinnati, United States · Last updated July 9, 2026

Overview

  • 6 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2017-11-08.

At a glance

Inspections

6

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
31 Oct 2017 – 8 Nov 2017Medical Devices & Rad Health483View 483 →
22 Jun 2015 – 7 Jul 2015Medical Devices & Rad HealthClean
22 Jun 2015 – 6 Jul 2015Medical Devices & Rad HealthClean
5 Jan 2012Not recordedClean
8 Dec 2010Not recordedClean
23 May 2003Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

8 Nov 2017
21 CFR 820.30(h)

Incorrect translation to production specifications

Cited by Christina L Bigham

8 Nov 2017
21 CFR 820.50(a)(2)

Supplier oversight

Cited by Christina L Bigham

8 Nov 2017
21 CFR 820.80(b)

Lack of or inadequate receiving acceptance procedures

Cited by Christina L Bigham

8 Nov 2017
21 CFR 820.90(b)(1)

Procedures for product review,disposition lack of/inadequate

Cited by Christina L Bigham

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.30(h)Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.80(b)Cited across public-safe Form 483 observations1x
21 CFR 820.90(b)(1)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Liebel-Flarsheim Company LLC's 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat